A twice-yearly injection may soon change how high blood pressure is treated. In a global trial, patients receiving the experimental drug zilebesiran alongside standard therapy saw greater blood pressure reductions than those on standard treatment alone. The drug works by blocking a key liver protein, helping blood vessels relax. Researchers say this long-lasting approach could make it much easier for patients to keep their condition under control.
source https://www.sciencedaily.com/releases/2026/04/260411022035.htm
Critrical cPanel flaw mass-exploited in "Sorry" ransomware attacks
-
A new disclosed cPanel flaw tracked as CVE-2026-41940 is being
mass-exploited to breach websites and encrypt data in "Sorry" ransomware
attacks. [...]
sou...
20 hours ago
No comments:
Post a Comment